Navigation Links
Senesco Technologies Closes Remaining $3.0 Million of Previously Announced Financing
Date:7/7/2008

ompany's annual report on Form 10-K and quarterly reports on Form 10-Q.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The shares of common stock have been sold pursuant to an exemption from state and federal securities laws.

About Senesco Technologies, Inc.

Senesco Technologies, Inc. is a U.S. biotechnology company, headquartered in New Brunswick, NJ. Senesco has initiated preclinical research to trigger or delay cell death in mammals (apoptosis) to determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain diseases inflammatory and ischemic diseases. Senesco takes its name from the scientific term for the aging of plant cells: senescence. Delaying cell breakdown in plants extends freshness after harvesting, while increasing crop yields, plant size and resistance to environmental stress. The Company believes that its technology can be used to develop superior strains of crops without any modification other than delaying natural plant senescence. Senesco has partnered with leading-edge companies engaged in agricultural biotechnology and earns research and development fees for applying its gene- regulating platform technology to enhance its partners' products.

Certain statements included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements expressed or implied herein as a result of a variety of factors, including, but not limited to: the Company's ability to raise additional capital to fund its research and development eff
'/>"/>

SOURCE Senesco Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Senesco Signs a Supply Agreement for Polyplus-transfections Delivery System
2. Senesco Technologies to Present at BIO 2008 Business Forum
3. Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results
4. Senesco Technologies Regains Compliance With Amexs Continued Listing Requirements
5. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
6. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
7. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
8. Neurobiological Technologies CEO to Retire on December 31, 2008
9. M. D. Anderson Automates Laboratory Workflow with Stone Bond Technologies : EE-LIMS™ from Stone Bond Technologies Will Document Activities within the Laboratory Workflow at the siRNA Facility, Increasing Throughput, While Reducing Risks
10. BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008
11. Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., COLUMBIA, Md., Dec. 2 /PRNewswire-FirstCall/ ... announced today that it intends to release the re...n December 16, 2009, at approximately 4:00 p.m. Ea....m. ET Martek will conduct a conference call to di...d parties may listen to the call live via webcast ...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportli...rt is available in its catalogue: ,, Drug Disc...nds & Opportunities ,, http://www.reportl...-Global-Update-of-Market-Trends--Opportunities.htm... ongoing element of every pharmaceutical company,s...
(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCall/ -...pany") (TSX:ONC; NASDAQ: ONCY ) announced today th...t offering, the underwriters have exercised in ful...itional 637,500 units. Each unit is comprised of o... warrant, and was sold at a price of US$3.00 per u...
(Date:12/2/2009)... , JERUSALEM, Israel, December 2 /PRNew...y study evaluating the preclinical (animal study) ...h combines technology from Weill,Cornell Medical C...tial to,treat inherited anemias such as Cooley,s A...es of technologies to expand, ex vivo,populations...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
...LONDON, Jan. 7 GlaxoSmithKline plc (LSE/NYSE: G...the tender offer by its wholly-owned subsidiary Ge...n stock of Genelabs Technologies, Inc. (Nasdaq: ..., New York City time, on Tuesday, January 6, 2009....sed GSK that shareholders of Genelabs have tendere...
... REDWOOD CITY, Calif., Jan. 7 Codexis, Inc. to...maceutical Industries Ltd., to produce an,importan...oprietary Codexis,biocatalyst. Teva, the largest ...ng producer of this generic product. The product ...n drugs in the United States. , Under the agre...
...BOSTON, Jan. 7 PAREXEL International Corporation ...nting at the 27th Annual JP Morgan Healthcare Conf... Josef von Rickenbach, Chairman and Chief Executi... PAREXEL at 10:00 a.m. PT on Tuesday, January 13, ...l be available by clicking on the following link ...
Other Biology Technology:GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc. 2Codexis, Teva in Licensing Agreement Final 2PAREXEL International to Present at the 27th Annual JP Morgan Healthcare Conference 2
(Date:12/3/2009)... , Our ability to learn new information and adapt ... retain lifelong memories, appears to lie in the m...ording to a new study by NYU Langone Medicine Cent... week in the journal Nature . , The scientists,...physiology and neuroscience at NYU School of Medic...
(Date:12/3/2009)... , ALBUQUERQUE, N.M. Most scientists believe that...ls that signal each other to emit toxins. The sign...y bacteria must be present to start the process. ,...ed that the very first stage of staph infection, w...form, occurs in a single cell and that this indivi...
(Date:12/3/2009)... , Spanish researchers have measured CO2 levels fo...tmosphere) over a sparsely inhabited rural area ne... their kind in the Iberian Peninsula, show that th...5. , Over recent years, physicists and meteorolog...xide (CO2) levels, and how these have evolved in t...
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2New Kodak Training Facility Showcases the Latest in Dental Technology Solutions from Advanced Automation 3A Networking Solutions Dental Practice Man 53647 1New Kodak Training Facility Showcases the Latest in Dental Technology Solutions from Advanced Automation 3A Networking Solutions Dental Practice Man 53647 2New Kodak Training Facility Showcases the Latest in Dental Technology Solutions from Advanced Automation 3A Networking Solutions Dental Practice Man 53647 3Access to Americas Orthopaedic Services Act of 2009 Introduced in the Senate 53642 1Access to Americas Orthopaedic Services Act of 2009 Introduced in the Senate 53642 2Access to Americas Orthopaedic Services Act of 2009 Introduced in the Senate 53642 3CMC Limited and FileVision LLC Announce Partnership to Provide Business Productivity Solutions to a Global Market 53637 1CMC Limited and FileVision LLC Announce Partnership to Provide Business Productivity Solutions to a Global Market 53637 2
...en after they have paired with a male, the female ... for sexual partners. And forget personality; the ...color of the males, breast and belly feathers. , I...les in the population, the female is more likely t...r male, according to a Cornell University study fe...
...unt Sinai School of Medicine researchers first to ...ormation for DNA replicationSince the discovery of...Crick in 1953, the paradigm for DNA replication ha...iate pairings for replication. , In other words, i...then its partner, a cytosine base, will pair to it...
...netic finding may have implications for farsighted...h-Mennonite family tree, Johns Hopkins researchers...appears to be the first human gene mutation that c...port that nanophthalmos, Greek for "dwarf eye," is...n alteration in a gene called MFRP that helps cont...
Other Biology News:Looks matter to female barn swallows 2Looks matter to female barn swallows 3Scientists focus on 'dwarf eye' 2Scientists focus on 'dwarf eye' 3
T4 DNA Polymerase from New England Biolabs
Alkaline Phosphatase, shrimp from Roche Applied Science
T4 DNA Polymerase from Invitrogen
...Ultrasonic Nebulizers are available in two product...between these two models is that the 6000AT+ inclu...reate a drier aerosol for improved detection limit...ances detection limits for a range of elements by ...
Biology Products: